Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
Crossref DOI link: https://doi.org/10.1186/1476-9255-12-S1-P5
Published Online: 2015-04-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arora, Jigyasa
Zwacka, Ralf Michael
Mohr, Andrea
Article History
First Online: 16 April 2015